Chinese Dragon's Blood EtOAc Extract Inhibits Liver Cancer Growth Through Downregulation of Smad3

• Main Authors: Xiaonan Chen (Author), Yanan Zhao (Author), Ailin Yang (Author), Yingying Tian (Author), Daoran Pang (Author), Jing Sun (Author), Leimengyuan Tang (Author), Huiming Huang (Author), Ying Wang (Author), Yunfang Zhao (Author), Pengfei Tu (Author), Zhongdong Hu (Author), Jun Li (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies, which ranks the third leading cause of cancer-related death worldwide. The screening of anti-HCC drug with high efficiency and low toxicity from traditional Chinese medicine (TCM) has attracted more and more attention. As a TC...